Key result
Metabolic syndrome linked to early diastolic dysfunction and myocardial fibrosis via mitochondrial and microvascular impairment.
Why the study?
This study was conducted to evaluate early structural and functional myocardial changes in patients with metabolic syndrome.
Observational
Metabolic syndrome is associated with early structural and functional myocardial changes, including diastolic dysfunction and fibrosis, underscoring the need for early diagnosis and treatment to prevent progression to heart failure.
May warrant cardiac monitoring in metabolic syndrome; leaves open causality of mitochondrial and microvascular defects in myocardial fibrosis.
This study aimed to evaluate early structural and functional myocardial changes in patients with metabolic syndrome. A clinico-morphological approach was applied, including anthropometric, biochemical, and echocardiographic assessments[1,2,3]. Insulin resistance was evaluated using the HOMA-IR index. The results demonstrated early diastolic dysfunction, mitochondrial impairment, and microvascular disturbances, contributing to fibrotic changes in the myocardium. These findings highlight the importance of early diagnosis and pathogenetic treatment to prevent progression to heart failure.
No takes yet. Share an insight, caveat, or question.
Nigoraxon Ravshanbek kizi Madraximova (2026) conducted an observational in Metabolic syndrome. Patients with metabolic syndrome demonstrated early diastolic dysfunction, mitochondrial impairment, and microvascular disturbances contributing to fibrotic changes in the myocardium.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: